MedTrace Logo

Long-term Follow-up of a Cochlear Implant With Dexamethasone Eluting Electrode Array

NCT06936449 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2025-12-15

No results posted yet for this study

Summary

A long-term follow-up of Cochlear's cochlear implant electrode array which passively elutes dexamethasone for a defined period of time to help reduce inflammatory responses.

Conditions

  • Sensorineural Hearing Loss
  • Bilateral Hearing Loss

Interventions

DEVICE

CI632D

CI632 cochlear implant with Slim Modiolar electrode including dexamethasone in the electrode within wells

DEVICE

CI632

CI632 cochlear implant with Slim Modiolar electrode with market approval and does not include dexamethasone

Sponsors & Collaborators

  • Cochlear

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-05
Primary Completion
2028-03-31
Completion
2028-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06936449 on ClinicalTrials.gov